Detalhe da pesquisa
1.
Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study.
Cancer
; 129(6): 946-955, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601958
2.
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
BMC Cancer
; 23(1): 738, 2023 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37563628
3.
ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide.
Pharmacogenomics J
; 20(2): 213-219, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31624332
4.
Genetic anticipation in Swedish Lynch syndrome families.
PLoS Genet
; 13(10): e1007012, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29088233
5.
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.
Acta Neuropathol
; 129(4): 597-607, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25724300
6.
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
JAMA
; 313(13): 1347-61, 2015 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25849179
7.
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Hum Mutat
; 33(4): 690-702, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22253144
8.
Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53).
Cancers (Basel)
; 14(2)2022 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35053544
9.
Prevalence of germline pathogenic variants in 22 cancer susceptibility genes in Swedish pediatric cancer patients.
Sci Rep
; 11(1): 5307, 2021 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674644
10.
A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients.
Sci Rep
; 11(1): 14763, 2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34285278
11.
Increased Cancer Risk in Families with Pediatric Cancer Is Associated with Gender, Age, Diagnosis, and Degree of Relation to the Child.
Cancer Epidemiol Biomarkers Prev
; 29(11): 2171-2179, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856606
12.
Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
Oncol Rep
; 36(5): 2823-2835, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27601186
13.
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma.
Oncotarget
; 6(18): 16663-73, 2015 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26143636
14.
A Novel SMAD4 Mutation Causing Severe Juvenile Polyposis Syndrome with Protein Losing Enteropathy, Immunodeficiency, and Hereditary Haemorrhagic Telangiectasia.
Case Rep Gastrointest Med
; 2015: 140616, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25705527
15.
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.
Cancer Epidemiol Biomarkers Prev
; 21(8): 1362-70, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22729394
16.
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
J Natl Cancer Inst
; 103(2): 105-16, 2011 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21169536
17.
A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer.
Breast Cancer Res Treat
; 106(1): 57-64, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17260097